Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.
about
Melanoma: oncogenic drivers and the immune systemBRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma modelA distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway.
P2860
Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@en
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@nl
type
label
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@en
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@nl
prefLabel
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@en
Loss of PI(4,5)P2 5-Phosphatas ...... a Cells to RAF/MEK Inhibitors.
@nl
P2093
P2860
P356
P1476
Loss of PI(4,5)P2 5-Phosphatas ...... ma Cells to RAF/MEK Inhibitors
@en
P2093
Hsin-Yi Tseng
Lin Jie Zhang
Wang Lai Hu
Xu Dong Zhang
P2860
P304
P356
10.1593/TLO.13277
P50
P577
2013-08-01T00:00:00Z